News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
167 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Business
Pilot Chemical Names Glynn Goertzen VP of Corporate Development
Pilot Chemical Company announced that Glynn Goertzen, president of Pilot Chemical subsidiary Liquid Minerals Group Ltd., also has been named vice president of corporate development for the parent company.
February 13, 2018
·
3 min read
Biotech Beach
Bionano Genomics Announces Global Launch of its New Direct Labeling Chemistry for Genome Mapping and Structural Variation Analysis
BioNano Genomics today announced the global commercial launch of new chemistry for sequence motif labeling called Direct Label and Stain.
February 13, 2018
·
4 min read
Genetown
MilliporeSigma Launches Viresolve Barrier Capsule Filters to Protect Against Bioreactor Contamination
MilliporeSigma today introduced Viresolve Barrier capsule filters to reduce the risk of bioreactor contamination.
February 13, 2018
·
3 min read
Affimed Announces Pricing of Public Offering of Common Stock
The offering is expected to close on or about February 15, 2018, subject to customary closing conditions.
February 13, 2018
·
3 min read
Biotech Bay
Kindred Biosciences to Participate in the Bank of America Merrill Lynch Animal Health Summit
KindredBio will participate in the Bank of America Merrill Lynch Animal Health Summit on February 26, 2018 in New York City.
February 13, 2018
·
1 min read
Business
Daré Bioscience Announces Proposed Public Offering of Common Stock
The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
February 13, 2018
·
3 min read
Drug Development
Neovacs Announces Positive Data Review from Last IDSMB Review Prior to Final Results of Phase IIb Clinical Trial of IFNalpha Kinoid in Lupus
This was the last IDSMB data review prior to the final results from this trial.
February 13, 2018
·
3 min read
BioMidwest
SCORR Marketing and Applied Clinical Trials Release Survey Report on Patient Engagement
SCORR Marketing, a global health science marketing and communications firm, has announced that a new Patient Engagement Survey Report is available for free download.
February 13, 2018
·
2 min read
Business
IBBL Confirms its Leading Role in Personalised Medicine With Another European Grant
IBBL will over the next three years contribute to the Interreg project Codex4SMEs.
February 13, 2018
·
2 min read
Business
Adaptive Biotechnologies Appoints Veteran Molecular Diagnostics Executive Michael Pellini, MD, to Board of Directors
As the former CEO and current Chairman of the Board of Directors of Foundation Medicine, Dr. Pellini led the development and commercialization of a suite of molecular information products and services to aid in the diagnosis and management of advanced cancer, and to optimize the discovery and development of novel oncology therapies.
February 13, 2018
·
3 min read
Previous
3 of 17
Next